Brawn Biotech Ltd

BSE :530207 NSE :- Sector : Pharmac..
22.00
Change: 0.65(3.04%)
No Graph Available
52 week Low
15.35
52 week High
27.82
Day low
22
Day high
22.39
Prev Close
21.35
Open
22.39
6M return
18.98%
1Y return
29.79%
MCap(Rs. in Cr.)
6.60
Total Volume
17
Face Value : 10
Listed Since
PE Ratio

Is the price-earnings ratio for valuing a company that measures its current share price relative to its earnings per share.

P/E RATIO
NM
EPS

The earnings per share ratio is a portion of company's net profit allocated for each outstanding share. It is calculated by deducting preferred stock divided from the net income of the company divided by the number of outstanding shares.

EPS
-5.48
PRICE/BOOK

Price-to-book ratio is used to compared the company's current market price with its book value.

PRICE/BOOK
1.56
Deliverable

These are the acutal number of shares that are traded on delivery based, meaning transfered from one person to another during the day's trade.

DELIVERABLES
94.12%
DIV YIELD.(%)

Dividend Yield measures the quantum of cash dividends paid to shareholders in a financial year relative to the market value of the per share.

DIV YIELD.(%)
0.00

Company Details

Check out the key parameters of the company to understand the financial health and stock performance

Key Level

Resistance 1
-
Resistance 2
-
Support 1
-
Support 2
-

Moving Average

20 Days
-
50 Days
-
100 Days
-
200 Days
-
Growth in 3 years

Sales
91.30%

Sales Industry Avg
17.44%

PAT
-23.78%

PAT Industry Avg
38.50%

Dec 2024
( in Cr.)
Sep 2024
( in Cr.)
Jun 2024
( in Cr.)
Mar 2024
( in Cr.)
FY 2024
( in Cr.)
Sales3.843.304.063.4516.49
Gross Profit-0.40-0.32-0.50-0.31-1.44
Operating Profit00000
Profit Before Tax-0.43-0.34-0.53-0.34-1.55
Tax0000-0.30
Profit After Tax-0.43-0.34-0.53-0.34-1.25
No data available
No data available


Relative to Sensex rtn in 3 year
-67.85%

Relative to Nifty rtn in 3 year
-69.28%



1 Year (%)2 Year (%)3 Year (%)
Brawn Biotech301010
Bse Sensex42531
Nifty 5042833

Peer Companies

A quick glance on how stocks from the same sector have performed along with some key parameters

Brawn Biotech
22.00
Change: 0.65 (3.04%)
1 Year return
29.79%
Risk (Std Dev)
0.16%
PE Ratio
NM
MCap( in Cr.)
6.60
Fermenta Biotec.
275.50
Change: -3.35 (-1.20%)
1 Year return
36.76%
Risk (Std Dev)
0.17%
PE Ratio
23.10273
MCap( in Cr.)
820.68
Bharat Parenter.
938.40
Change: -4.05 (-0.43%)
1 Year return
-16.14%
Risk (Std Dev)
0.28%
PE Ratio
NM
MCap( in Cr.)
649.53
Jenburkt Pharma
975.00
Change: 8.30 (0.86%)
1 Year return
22.95%
Risk (Std Dev)
0.13%
PE Ratio
13.58
MCap( in Cr.)
426.63
Kerala Ayurveda
319.00
Change: 5.50 (1.75%)
1 Year return
14.79%
Risk (Std Dev)
0.16%
PE Ratio
505.64516
MCap( in Cr.)
377.22
View More

Return Calculator

This tools helps you project your potential return on investments for the given stock, for a specified amount over a per-defined period of time.

 

If I had made
investment of  
in
Months Ago
My investment would be worth 1,29,793.50 with a Gain of 29.79%

News

Stay tuned to the latest developments and happenings in the company.

Brawn Biotech reports standalone net loss of Rs 0.43 crore in the December 2024 quarter

Net Loss of Brawn Biotech reported to Rs 0.43 crore in the quarter ended December 2024 as against net loss of Rs 0.61 crore during the previous quarte....

12 Feb 2025 17:52

Brawn Biotech to table results

Brawn Biotech will hold a meeting of the Board of Directors of the Company on 12 February 2025.Powered by Capital Market - Live News<....

05 Feb 2025 12:58

Brawn Biotech reports standalone net loss of Rs 0.34 crore in the September 2024 quarter

Net Loss of Brawn Biotech reported to Rs 0.34 crore in the quarter ended September 2024 as against net loss of Rs 0.42 crore during the previous quart....

14 Nov 2024 17:48

Brawn Biotech to conduct board meeting

Brawn Biotech will hold a meeting of the Board of Directors of the Company on 14 November 2024Powered by Capital Market - Live News</....

11 Nov 2024 12:21

Brawn Biotech to conduct AGM

Brawn Biotech announced that the 39th Annual General Meeting (AGM) of the company will be held on 30 September 2024.Powered by Capital Ma....

05 Sep 2024 15:14

Brawn Biotech reports standalone net loss of Rs 0.53 crore in the June 2024 quarter

Net Loss of Brawn Biotech reported to Rs 0.53 crore in the quarter ended June 2024 as against net loss of Rs 0.17 crore during the previous quarter en....

14 Aug 2024 17:09

View More
Subscribe for our
newsletter
Open Account Now